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Abstract
Introduction: Severe infection and sepsis are common causes of morbidity and mortality. Early diagnosis in
critically ill patients is important to reduce these complications. The present study was conducted to determine the
role of serum leptin at early diagnosis and differentiation between patients with manifestations of systemic
inflammatory response syndrome (SIRS) and those with sepsis in patients suffering from a broad range of diseases
in the intensive care unit (ICU) and its correlation with other biomarkers, such as C-reactive protein (CRP),
interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a).
Methods: One hundred and six adult ICU patients were observed. CRP, leptin, IL-6 and TNF-a were compared
among the following groups: sepsis group (n = 40), SIRS group (n = 34) and non-SIRS group (n = 32). Patients
were classified into these groups at the time of blood analysis for these biomarkers.
Results: Non-significant differences were observed among patients in different groups regarding biomarkers on
the day of ICU admission. On the second day of ICU admission, significant elevation of leptin, IL-6 and TNF-a
occurred in the SIRS and sepsis groups. Delayed elevation of CRP started on the fourth day of ICU admission in
patients with sepsis. At the end of the first week, only CRP level was elevated in septic patients.
Conclusions: Serum leptin correlates well with serum level of IL-6 and TNF-a. Leptin helps to differentiate SIRS
from non-SIRS patients. CRP is a classic marker of sepsis but is of late onset.
Introduction
Severe infection and sepsis are major reasons for inten-
sive care unit (ICU) admission and leading causes for
mortality in non-coronary ICUs [1]. Infections and sep-
sis are accompanied by clinical and laboratory signs
such as changes in body temperature, leucocytosis, and
tachycardia. However, these signs of systemic inflamma-
tion may have infectious or non-infectious etiologies
and are neither specific nor sensitive for sepsis [2].
Fever and leucocytosis, the classical markers of infec-
tion, have only moderate sensitivity and specificity.
Fever was absent in 55% of cases of peritoneal infection
while leucocytosis was absent in 35%. Early markers of
septic complication would be useful for the diagnosis
and treatment of sepsis [3]. C-reactive protein (CRP)
has been used to follow septic patients but is a poor
diagnostic and prognostic indicator because of the time
t a k e nt op r o d u c ear e a c t i o na n dt h ed u r a t i o no ft h e
increase in serum concentration [4].
The systemic release of inflammatory cytokines occurs
several hours earlier than the release of other markers
of systemic inflammation such as acute phase protein
and leucocytosis, suggesting their potential importance
as diagnostic parameters in systemic inflammatory
response syndrome (SIRS) and post-surgery sepsis [5].
Although cytokines such as interleukin-6 (IL-6) have
been shown to relate to the severity of sepsis and
patients outcome, they are not established tools for
diagnosis and clinical decision making. However, IL-6 is
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operative sepsis, severe sepsis and septic shock [6].
Many published works have focused on the role of solu-
ble tumor necrosis factor-a (TNF-a) as an important
cytokine in inflammatory states including sepsis [7].
Leptin is an adipocyte secreted hormone. In addition
to playing a role in energy regulation, leptin also regu-
lates endocrine and immune function. It plays a role in
innate and acquired immunity. Both the structure of
leptin and that of its receptor suggest that leptin can be
classified as a cytokine [8]. The present study was con-
ducted to determine the role of serum leptin at early
diagnosis and differentiation between patients with man-
ifestations of SIRS and those with sepsis in patients suf-
fering from a broad range of diseases in ICU and its
correlation with other biomarkers.
Materials and methods
After the study was approved by an investigational
review board, an informed consent was obtained from
patients participating in the study or from their relatives.
The study was conducted over a period of nine months
in the ICU of Emergency Hospital of Tanta University,
Tanta, Egypt, which is a 25-bed medical/surgical ICU.
One hundred and six adult ICU patients were observed.
CRP, leptin, IL-6 and TNF-a were compared among the
following groups: sepsis group (n = 40), systemic inflam-
matory response syndrome (SIRS) group (n = 34) and
non-systemic inflammatory response syndrome (non-
SIRS) group (n = 32), to act as a control or reference
group. Patients were classified into these groups at the
time of the first blood analysis for these biomarkers at
ICU admission. All patients staying for more than
24 hours in the ICU were consecutively enrolled in the
study. Patients who had received anti-inflammatory
drugs or corticosteroids before admission, who had
immunosuppressive illness, who had chronic organ fail-
ure, who had received massive blood transfusion, or
whose anticipated duration of stay was under 24 hours
were excluded from the study. At admission, the
patient’s age, sex, height and weight were recorded.
Also, data were collected in the second, third and fourth
days of ICU stay, then weekly, and on the day of dis-
charge. These data include the following: clinical status:
sequential organ failure assessment (SOFA) score; tem-
perature; heart rate; respiratory rate; blood pressure;
central venous pressure; laboratory analysis (complete
blood count, blood urea nitrogen, blood sugar, serum
sodium, potassium, calcium, aspartate aminotransferase,
alanine aminotransferase, prothrombin time, albumin,
CRP, leptin, IL-6 and TNF-a) and arterial blood gas
analysis. Routine cultures of blood, urine and suspected
sites were obtained to determine the presence of infec-
tion. We attempted to maintain the patient’s
hemoglobin level at 10 to 12 g/dl and central venous
pressure at 8 to 12 cm H2O. If needed, blood products,
intravascular fluid replacement and inotropic and/or
vasopressor agents were administered. Each day the
attending physician in the ICU evaluated all the study
patients for SIRS, sepsis, severe sepsis, or septic shock.
Sepsis was defined as SIRS associated with infection
according to Bones’ criteria [9]. The signs of SIRS were
body temperature <33.6°C or >38.3°C, tachycardia (>90
beats/minute), ventilatory frequency >20 breaths/minute
or PCO2 <32 mmHg (unless the patient was mechani-
cally ventilated), a white cell count ≥12 × 10
9 litre
-1 or
<4 × 10
9 litre
-1 or >10% immature neutrophils. Severe
sepsis was defined as sepsis with evidence of organ dys-
function and hypoperfusion, acute alteration of mental
status, elevated plasma lactate, unexplained metabolic
acidosis (arterial pH <7.3), hypoxaemia, prolonged pro-
thrombin time or a decrease in platelet count >50% or
≤100 × 10
9litre
1, oliguria and hypotension defined as
systolic arterial pressure <90 mmHg or a decrease of
>40 mmHg. Septic shock was defined as hypotension
(<90/60 mmHg) in addition to sepsis syndrome persist-
ing despite adequate fluid resuscitation and requiring
intropic support. The SOFA score is composed of scores
from six organ systems (respiratory (R), cardiovascular
(C), hepatic (H), coagulation (Co), renal (Re), and neu-
rological (N)) graded from 0 to 4 according to the
degree of dysfunction/failure. The aggregate score (total
maximum SOFA score (TMS) is calculated, summing
up the worst scores for each of the organ systems
(TMSorg) during the ICU stay [10].
Blood sampling
Blood samples were collected in glass tubes. Blood was
processed within two hours. It was centrifuged at 1,600
g for 15 minutes.
IL-6 and TNF-a determination using ELISA
S e r u ml e v e l so fI L - 6a n dT N F - a were determined by
quantitative sandwich enzyme immunoassay (R&D Sys-
tems, Inc., Minneapolis, MN, USA) according to the
manufacturer’s instructions. The intensity of the colour
was measured at 490 nm for both IL-6 and TNF-a.
Leptin determination
Serum leptin was determined by quantitative sandwich
enzyme immunoassay (Ray Biotech., Inc., Minneapolis,
MN, USA) according to the manufacture’s instructions.
The intensity of the colour was measured at 450 nm.
Statistical analysis
Parametric data were analyzed using either ANOVA or
Student’s t-test while non-parametric data were analyzed
using Mann-Whitney U and c
2-tests. Data were pre-
sented as mean and standard deviation. A P-value of
< 0.05 was considered significant.
Yousef et al. Critical Care 2010, 14:R33
http://ccforum.com/content/14/2/R33
Page 2 of 9Results
Patients’ characteristics
A total of 106 patients (57 men and 49 women) were
included in the study. Forty patients developed septic
complications during their ICU stay (sepsis group), 12
developed septic shock, 18 developed severe sepsis,
and 10 patients developed sepsis without any organ
dysfunction. Thirty-four patients developed manifesta-
tions of SIRS without evidence of infectious organisms
(SIRS group), 10 developed non-septic complications
in the form of disturbed hepatic or renal functions,
electrolyte imbalance or acid-base disorders. Thirty-
two medico-surgical patients showed no manifestation
of SIRS (non-SIRS group). Eleven patients died, eight
of whom were in septic shock and the other three
were suffering from severe sepsis. There was no signifi-
cant difference among the groups, except for SOFA
scores at ICU admission and the duration of the stay
in the ICU; SOFA scores were higher in septic patients
(Table 1).
The mean values of CRP at admission were 47 mg/dl
in non-SIRS patients, 52 mg/dl in SIRS and 67 mg/dl in
septic patients. On the second day, the mean value was
59 mg/dl in non-SIRS patients, 65 mg/dl in SIRS and
78 mg/dl in septic patients.
IL-6 mean values were nearly equal among groups and
no significant differences were found between the admis-
sion values; mean IL-6 level was 7.4 pg/ml in non-SIRS,
8.5 pg/ml in SIRS and 9.6 pg/ml in septic patients, but on
the second day there was a significant increase in the
mean value in SIRS and septic patients: 275 pg/ml and
485 pg/ml respectively versus 21.4 pg/ml in non-SIRS
patients (P = 0.004).
The admission mean value of TNF-a was 23.9 pg/ml
in non-SIRS patients, 24.8 pg/ml in SIRS and 27.6 pg/ml
in septic patients, but on the second day there was a sig-
nificant increase in the mean value in SIRS and septic
patients of 382 pg/ml and 407 pg/ml, respectively, ver-
sus 36 pg/ml in non-SIRS patients (P = 0.0032). The
admission serum leptin mean values were nearly equal
among patients in the different groups, they were
2.76 μg/l in non-SIRS, 2.94 μg/I in SIRS and 3.25 μg/l in
septic patients, the second day levels significantly
increased in septic and SIRS but not in non-SIRS
patients, the mean value was 3.4 μg/l in non-SIRS com-
pared to 30.5 μg/l in SIRS and 44.7 μg/I in septic
patients (P = 0.005) (Table 2).
A positive correlation was found among leptin, IL-6
and TNF-a in both SIRS and sepsis groups (Figures 1,
2, 3 and 4).
On the fourth day of the ICU stay, a significant eleva-
tion of mean value of CRP occurred in septic patients.
The mean value of serum leptin, IL-6 and TNF-a
declined in SIRS and septic patients but was still signifi-
cantly elevated (Table 3).
At the end of the first week of the ICU stay, there was
only significant elevation of mean value of CRP in septic
patients. There was no significant change in the mean
value of serum leptin, IL-6 and TNF-a among the dif-
ferent groups (Table 4).
The accuracy of serum leptin in distinguishing non-
SIRS patients from SIRS and septic patients is shown in
Figure 5. A cut-off point set at 5.1 μg/l leptin had a sen-
sitivity of 100% and specificity of 100%. The accuracy of
serum leptin in distinguishing SIRS patients from septic
patients is shown in Figure 6. A cut-off point set at 38
μg/l leptin gives a sensitivity of 91.2% and a specificity
of 85%.
Discussion
Prompt diagnosis and treatment with appropriate anti-
microbial chemotherapy is of the utmost importance in
Table 1 Patient characteristics (mean and standard
deviation)
Sepsis
group
(n = 40)
SIRS
group
(n = 34)
Non-SIRS
group
(n = 32)
Age (years) 42 ± 10.5 46 ± 9.7 40 ± 8.2
Sex ratio (M/F) 21/19 18/16 18/14
SOFA score 11 (8 to 13)* 5 (3 to 8) 3 (2 to 5)
Duration of ICU stay 12.8 ± 3.6* 4.9 ± 2.2 4.4 ± 1.9
Diagnosis
Respiratory insufficiency
due to:
10 9 10
Bacterial infection. 6
Viral infection. 4
ARDS. 9
COPD. 4
Bronchial asthma. 3
Pulmonary edema. 3
Polytrauma 98 7
Orthopedic surgery 14 11 10
Thoracic surgery 76 5
*Significant change (P < 0.05). M/F, male/female; ICU, intensive care unit; SIRS,
systemic inflammatory response syndrome; ARDS, adult respiratory distress
syndrome; COPD, chronic obstructive pulmonary disease.
Table 2 Mean values of CRP, leptin, IL-6, and TNF-a
levels at the second day of ICU stay
CRP
mg/dl
Leptin
μg/l
IL-6
pg/ml
TNF-a
pg/ml
Non-SIRS group 59 3.4 21.4 36
SIRS group 65 30.5* 275* 382*
Sepsis group 78 44.7* 485* 407*
*Significant change (P < 0.05). CRP, c - reactive protein; IL-6, interleukin-6;
TNF-a, tumor necrosis factor-alpha; ICU, intensive care unit.
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sepsis. The lack of specific early markers of infection
may be responsible in part for withholding, delaying or
using unnecessary antimicrobial treatment in critically
ill patients. Thus, there is a need for laboratory tools
that can distinguish between SIRS and sepsis [11]. In 20
to 30% of patients, the infection site is never identified.
Neither imaging studies nor blood culture analysis can
rule out the presence of infection. Moreover, there are
classes of patients with unconfirmed infection, or for
whom cultures are negative, yet they develop similar
symptoms [12].
Figure 1 Correlation between leptin and TNF-a in SIRS group. Significant positive correlation between leptin and TNF-a in SIRS group.
Figure 2 Correlation between leptin and TNF-a in sepsis group. Significant positive correlation between leptin and TNF-a in sepsis group.
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low septic patients, but these concentrations did not pre-
dict the outcome of disease and severity. The use of CRP
concentrations has failed to allow immediate diagnosis and
prognosis because of the time taken to produce a reaction
and the duration of increased serum concentration. These
facts may explain the lower sensitivity of CRP in the early
postoperative period [13]. Povoa et al. [14] concluded that
daily CRP determination could be useful as a marker of the
prediction of infection. Both temperature and white cell
Figure 4 Correlation between leptin and IL-6 in sepsis group. Significant positive correlation between leptin and IL-6 in sepsis group.
Figure 3 Correlation between leptin and IL-6 in SIRS group. Significant positive correlation between leptin and IL-6 in SIRS group.
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levels at the fourth day of ICU stay
CRP
mg/dl
Leptin
μg/l
IL-6
pg/ml
TNF-a
pg/ml
Non-SIRS group 62 4.2 24.5 42.7
SIRS group 70 16.9* 184* 164*
Sepsis group 196* 18.6* 204* 179*
*Significant change (P < 0.05). CRP, c - reactive protein; IL-6, interleukin-6;
TNF-a, tumor necrosis factor-alpha; ICU, intensive care unit.
Table 4 Mean value of CRP, leptin, IL-6 and TNF-a levels
at the end of the first week of ICU stay
CRP
mg/dl
Leptin
μg/l
IL-6
pg/ml
TNF-a
pg/ml
Non-SIRS group 56 4.6 23.9 47.8
SIRS group 64 4.9 25.8 49.5
Sepsis group 162* 5.3 26.2 53.4
*Significant change (P < 0.05). CRP, c - reactive protein; IL-6, interleukin-6;
TNF-a, tumor necrosis factor-alpha; ICU, intensive care unit.
Figure 5 Receiver operator curve of serum leptin between non-SIRS versus SIRS and sepsis groups.
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process. A criticism of the work is the lack of monitoring
of the other inflammatory bio-markers which would be
more useful if they were combined with serial CRP deter-
mination. It is known that the persistence of TNF-a [15]
and IL-6 in the serum peak levels of cytokines reveals the
onset of sepsis and predicts poor outcome in septic
patients [16]. Leptin is involved in the network of inflam-
matory mediators and during SIRS its plasma concentra-
tion increases by the action of these inflammatory
mediators [17]. During a non-infectious stress response,
leptin is an acute phase reactant. Studies by Maruna et al.,
[18] and Yamaguchi et al., [19] demonstrated that a signifi-
cant correlation between leptin and TNF-alpha can be a
crucial regulator of leptin generation. It is possible that
pro-inflammatory cytokines induces an obesity gene (OB)
transcription in vivo through secondary mediators such as
transforming growth factor-b [20]. However, Chachkhiani
et al. [5] observed that during the first 24 hours after colo-
nic resection there is a significant increase in serum IL-6
which declined during the first 48 to 72 hours. Serum
TNF-a was highest 18 to 24 hours after surgery and there
was a significant elevation of plasma leptin concentration
24 hours postoperative, which rapidly returned to preo-
perative value 48 to 72 hours later. The concentration of
leptin fails to differentiate the onset of sepsis from a non-
complicated course. Bornstein et al. [21] found that the
mean plasma leptin levels were three-fold higher in criti-
cally ill septic patients than healthy control adults and con-
cluded that leptin is a stress related hormone and its role
in sepsis represents an acute stress mediated response
which participates in the sickness syndrome.
Conclusions
Serum leptin increases in SIRS and sepsis and is
strongly related to circulating levels of TNF-a,I L - 6 .
Serum leptin is a powerful biomarker of SIRS patients
with or without infection.
Key messages
￿ Early diagnosis and differentiation of critically ill
patients is crucial for better prognosis.
￿ Differentiation of sepsis is of utmost importance
for early direction of proper anti-microbial therapy.
￿ Inflammatory mediators monitored in critically ill
patients such as TNF-a and IL-6 have moderate effi-
cacy and specificity for differentiation of critically ill
patients.
￿ A positive correlation between leptin and inflam-
matory mediator TNF-a a n dI L - 6i sp r o v e ni nc r i t i -
cally ill septic patients.
￿ Leptin monitoring is associated with a high degree
of efficacy and specificity for differentiation of sepsis.
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